JOHNSON & JOHNSON — Investor Relations & Filings
Filings indexed
3,104
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
JNJ
Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2026 | 2026-05-13 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English | |
| 8-K | 2026-04-27 | English | |
| 10-Q - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-04-22 | English | |
| 8-K - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-04-14 | English | |
| Major Shareholding Notification 2026 | 2026-04-13 | English |
Browse filings by year
27 years- 2026 48 filings
- 2025 125 filings
- 2024 142 filings
- 2023 172 filings
- 2022 136 filings
- 2021 88 filings
- 2020 128 filings
- 2019 78 filings
- 2018 85 filings
- 2017 91 filings
- 2016 101 filings
- 2015 86 filings
- 2014 99 filings
- 2013 97 filings
- 2012 105 filings
- 2011 163 filings
- 2010 131 filings
- 2009 142 filings
- 2008 155 filings
- 2007 155 filings
- 2006 174 filings
- 2005 151 filings
- 2004 165 filings
- 2003 158 filings
- 2002 71 filings
- 2001 38 filings
- 2000 20 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46004770 | Regulatory Filings 2026 | 2026-05-13 | English | ||
| 46004783 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46004779 | 8-K | 2026-04-27 | English | ||
| 35389314 | 10-Q - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-04-22 | English | ||
| 34481934 | 8-K - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-04-14 | English | ||
| 46004787 | Major Shareholding Notification 2026 | 2026-04-13 | English | ||
| 33049445 | SCHEDULE 13G/A - JOHNSON & JOHNSON (0000200406) (Subject) | 2026-03-26 | English | ||
| 32977191 | 13F-HR/A - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-03-18 | English | ||
| 32976926 | 13F-HR/A - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-03-18 | English | ||
| 46004793 | ANNUAL REPORT TO SECURITY HOLDERS | 2026-03-11 | English | ||
| 46004813 | DEFA14A | 2026-03-11 | English | ||
| 46004924 | DEF 14A | 2026-03-11 | English | ||
| 32879162 | 4 - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-03-03 | English | ||
| 32879163 | 4 - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-02-23 | English | ||
| 32879164 | 4 - JOHNSON & JOHNSON (0000200406) (Filer) | 2026-02-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Irwin Naturals Inc.
Nutraceutical company distributing premium soft-gel supplem…
|
IWIN | CA | Manufacturing |
|
Ishita Drugs & Industries Ltd.
Produces APIs, drug intermediates, and folic acid for globa…
|
524400 | IN | Manufacturing |
|
Isodiol International Inc.
Develops and distributes hemp-based consumer goods and high…
|
ISOLF | CA | Manufacturing |
|
IsoTis S.A.
Specialized in proprietary orthobiologics products for the …
|
ISON | CA | Manufacturing |
|
ISU Abxis Co., Ltd.
Develops antibody-based immunotherapies for oncology and ra…
|
086890 | KR | Manufacturing |
|
Iterum Therapeutics plc
Develops and commercializes anti-infectives for multi-drug …
|
ITRM | US | Manufacturing |
|
IX BIOPHARMA LTD.
A specialty pharmaceutical and nutraceutical company develo…
|
42C | SG | Manufacturing |
|
Jacobio Pharmaceuticals Group Co., Ltd.
Biopharma specializing in innovative oncology therapies dis…
|
1167 | KY | Manufacturing |
|
Jacobson Pharma Corporation Limited
Leading regional pharmaceutical group specializing in the p…
|
2633 | HK | Manufacturing |
|
Jagsonpal Pharmaceuticals Limited
Develops and markets formulations for gynecology, orthopedi…
|
JAGSNPHARM | IN | Manufacturing |
JOHNSON & JOHNSON via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29750/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29750 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29750 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29750 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29750}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for JOHNSON & JOHNSON (id: 29750)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.